DSM-5 recognizes hoarding disorder as distinct from obsessive-compulsive disorder (OCD), codifying a new consensus. Hoarding disorder was previously classified as a symptom of OCD and patients received treatments designed for OCD. We conducted a meta-analysis to determine whether OCD patients with hoarding symptoms responded differently to traditional OCD treatments compared with OCD patients without hoarding symptoms. An electronic search was conducted for eligible studies in PubMed. A trial was eligible for inclusion if it (1) was a randomized controlled trial, cohort or case-control study; (2) compared treatment response between OCD patients with and those without hoarding symptoms, or examined response to treatment between OCD symptom dimensions (which typically include hoarding) and (3) examined treatment response to pharmacotherapy, behavioral therapy or their combination. Our primary outcome was differential treatment response between OCD patients with and those without hoarding symptoms, expressed as an odds ratio (OR). Twenty-one studies involving 3039 total participants including 304 with hoarding symptoms were included. Patients with OCD and hoarding symptoms were significantly less likely to respond to traditional OCD treatments than OCD patients without hoarding symptoms (OR = 0.50 (95% confidence interval 0.42-0.60), z = − 7.5, Po 0.0001). This finding was consistent across treatment modalities. OCD patients with hoarding symptoms represent a population in need of further treatment research. OCD patients with hoarding symptoms may benefit more from interventions specifically targeting their hoarding symptoms.
INTRODUCTION DSM-5 recognizes hoarding disorder as being distinct from obsessive-compulsive disorder (OCD). 1 Hoarding disorder is characterized by (1) persistent difficulty in discarding or parting with possessions, regardless of their actual value; (2) a perceived need to save items and distress associated with discarding them, which results in (3) the accumulation of possessions that clutter living areas and compromises their intended use. 1 Patients with hoarding symptoms have been known to build up so much clutter that they cannot complete daily activities such as cooking, cleaning, or moving around their house. Hoarding disorder is estimated to affect 1.5% of the population and, left untreated, can cause occupational problems and have a significant public health impact. 2 Until DSM-5, hoarding symptoms were often classified as an aspect of OCD. 3 The expressed cognitions of many individuals who hoard can be understood in this light-obsessions characterized by a fear of losing things and compulsions to acquire and save objects. However, a number of factors suggest that hoarding may be a unique variation or even a disorder entirely discrete from OCD, despite frequent comorbidity. More than 80% of individuals with hoarding symptoms do not show any of the core symptoms of OCD. [4] [5] [6] Hoarding symptoms are more often comorbid with major depression, social phobia, and generalized anxiety disorder than with OCD. 5 While OCD patients typically have some insight into their condition, patients with hoarding symptoms frequently do not and find built up clutter, rather than the underlying behaviors that lead to it, to be more of an issue. 7 Unlike obsessions, hoarding thoughts are not generally experienced as unsettling or intrusive; instead they feel like a normal stream of thought. 8 A series of factor and cluster analytic studies in OCD patients have consistently identified hoarding symptoms as a distinct entity. 9 Experts have suggested that the two disorders are neurobiologically distinct, with patients with hoarding symptoms displaying a unique pattern of resting brain function and different symptom-regulating neural circuits than OCD patients. [10] [11] [12] [13] Furthermore, there are preliminary findings which suggest that OCD and hoarding may have different genetic origins. [14] [15] [16] Because of hoarding's previous classification in DSM-IV with OCD, patients with prominent hoarding symptoms have, until recently, typically been presented with treatment options similar to those for OCD patients, and the majority of the treatment research on patients with hoarding symptoms has occurred in patients in OCD trials rather than specifically in identified hoarding populations. These treatment options include selective serotonin reuptake inhibitors and cognitive behavioral therapy. 17 Few treatment studies have been conducted specifically in patients with hoarding symptoms. 18, 19 Patients with hoarding symptoms have been reported to have poor treatment response compared with other OCD patients in some studies, although not in all (see below). The purpose of our meta-analysis was to determine whether OCD patients with hoarding symptoms have a worse response to traditional OCD treatments compared with OCD patients without hoarding symptoms. We also sought to determine the magnitude of the difference in treatment response and whether it is specific to the type of intervention (cognitive behavioral therapy or pharmacotherapy). 
MATERIALS AND METHODS

Inclusion criteria
A trial was eligible for inclusion in our meta-analysis if it (1) was a randomized controlled trial, cohort or case-control study; (2) compared treatment response between OCD patients with and those without hoarding symptoms, or examined response to treatment between OCD symptom dimensions (which typically include hoarding) 20 and (3) examined treatment response to pharmacotherapy, behavioral therapy, their combination or placebo. Trials were excluded if they did not study OCD patients with and without hoarding symptoms or if they did not examine response to pharmacotherapy, behavioral therapy or placebo. We found only one study that compared placebo response in patients with hoarding symptoms to patients without hoarding symptoms, so we excluded this as an outcome. 21 Meta-analytic procedure Data from the included articles were organized into an Excel spreadsheet. We extracted age (child or adult sample), treatment type (pharmacotherapy, behavioral therapy or placebo), response criteria utilized in studies, and the number of OCD patients with hoarding symptoms and OCD patients without hoarding symptoms included in the trial. From each study, the proportion of treatment responders in OCD patients with hoarding symptoms and OCD patients without hoarding symptoms was recorded. OCD patients were defined as having hoarding symptoms based on the criteria defined in the primary studies. When the proportion of treatment responders was not available in mean and standard deviation of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), 22, 23 improvement was recorded for each group. If neither of the first two outcomes were available then mean and standard deviation of the Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS) hoarding and other subscales were recorded. 24 Our primary outcome measure was an odds ratio (OR) of treatment response in OCD patients with and without hoarding symptoms. All statistical analyses were performed using Comprehensive Meta-Analysis version 2 (CMA; Biostat, Englewood, NJ, USA). Effect sizes of trials whose outcomes were reported as a continuous measure were converted to OR as a summary measure in CMA. Standardized mean difference is converted to OR in CMA using the formula ln (OR) = π × SMD/√3. A fixed (as opposed to random) effects model was used for the meta-analysis because there was a strong possibility of publication bias in the results, which is more likely to be published or reported in sufficient detail for meta-analysis if the results are positive. Fixed effects models give less weight to small studies compared with random-effects models and thus are considered more appropriate in situations where there are concerns of publication bias. We report the results of a random-effects model as an additional sensitivity analysis. We conducted an additional sensitivity analysis excluding studies in which the OR was estimated from continuous rating scales.
Heterogeneity between studies was determined by means of two separate statistical estimates using CMA. First, a Q-statistic was employed to provide a test of statistical significance indicating whether the differences in effect sizes occur due to subject-level sampling error alone or other sources. In addition, we estimated heterogeneity using I 2 -statistic, which estimates the proportion of total variance that can be attributed to between-study variance. Publication bias was assessed by plotting the effect size against standard error for each trial (funnel plot). 25 In addition, publication bias was statistically tested by the Egger's test. 25 We conducted a stratified subgroup analyses to examine the effects of (1) type of intervention utilized-(pharmacotherapy, behavioral therapy or combination treatment), (2) age (child vs adult sample) and (3) method for assessing treatment response. For method for assessing treatment response we stratified studies based on whether they classified treatment response as a dichotomous outcome by (1) reduction in Y-BOCS, (2) CGI or (3) combination of both CGI and Y-BOCS criteria or by examining symptom reduction as a continuous measures using the (4) Y-BOCS or (5) DY-BOCS. For stratified subgroup analyses, we examined whether stratification significantly reduced heterogeneity as measured by the Q-statistic.
RESULTS
Included studies
In all, 21 studies with a total of 3039 participants were included in this meta-analysis. 21, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] Figure 1 shows the selection of these studies from the 414 results returned by our PubMed search and identified from relevant reviews. Seven of these studies (involving eight comparison arms) examined the efficacy of behavioral therapy, seven of pharmacotherapy, and seven of combination treatment with pharmacotherapy and behavioral therapy. The characteristics of the 21 studies are depicted in Table 1 .
Treatment response in OCD patients with and without hoarding symptoms 
DISCUSSION
Our meta-analysis showed a strong association between hoarding symptoms and poor response to traditional OCD treatment. OCD patients with hoarding symptoms were roughly 50% (range 40-58%) less likely to respond to traditional OCD treatments compared with OCD patients without hoarding symptoms. These findings reinforce the widespread clinical perception that the presence of hoarding symptoms is often a predictor of poor response to either cognitive behavioral or pharmacological interventions for OCD. Our results extend this perception by demonstrating that hoarding symptoms were associated to a comparable degree with poor treatment response regardless of treatment modality. The poor response to treatment (regardless of modality) observed in OCD patients with hoarding symptoms could be attributable to a variety of factors. Hoarding symptoms in OCD have been previously associated with poor insight and increased comorbidity with major depressive disorder, social phobia, posttraumatic stress disorder and impulse-control disorders. 5, [46] [47] [48] These factors may contribute to decreased treatment compliance in OCD patients with hoarding symptoms. In fact, hoarding symptoms in OCD patients have been associated with poor compliance with behavioral treatments. 42 Hoarding symptoms may also have a different underlying etiology that may be less responsive to treatment than other OCD symptoms.
The differing treatment response between OCD patients with and without hoarding symptoms highlights an emerging distinction between hoarding symptoms and OCD. As previously stated, there are many factors which suggest that hoarding is not just a subtype of OCD. The majority of patients with prominent hoarding symptoms do not have significant OCD symptoms. In addition, neuroimaging studies have suggested differing neurocircuitry in patients with prominent hoarding symptoms compared with non-hoarding OCD patients. 10-13, Likewise, genetic studies have demonstrated genes associated with hoarding but not with nonhoarding OCD. 49 We demonstrate a clearly reduced treatment response in OCD patients with hoarding symptoms to current firstline interventions for OCD.
Our meta-analysis had several limitations. We only searched the PubMed data set, which may have missed unpublished or non-English language studies. We also had a fairly small number of studies, especially when stratifying for different treatment modalities and the age of the participants. Therefore we could only examine a subset of potentially important moderators. Additional moderators that would have been worth examining if more studies were available include: duration of treatment, doses of medication, severity of symptoms, facets of behavioral therapies, previous treatment history and presence of other OCD symptoms in hoarding subjects. The fairly small number of studies also gave us limited power to detect moderating effects of the variables we could examine. There was a moderate amount of heterogeneity between study results. This heterogeneity may be attributable to different definitions of treatment response and different criteria for having hoarding symptoms between included studies. Other possible sources of heterogeneity that could not be explored in this meta-analysis are the impact of symptom severity, comorbid conditions and duration or quality of treatment. In addition, included studies involved OCD patients with primary hoarding symptoms and did not include hoarding patients without OCD symptoms in study samples. This may limit the generalizability of the results of the current meta-analysis to patients diagnosed with hoarding disorders by the DSM-5 criteria. 9 However, to our knowledge only one study compared pharmacological response in patients with hoarding symptoms (without OCD symptoms) with that in OCD patients. This study demonstrated a nonsignificantly worse treatment response in patients with hoarding symptoms that was fairly consistent with the results of the meta-analysis. Another limitation of this meta-analysis is the use of the Y-BOCS scale as an outcome measure for most of these trials. The Y-BOCS scale is the gold-standard for measurement of OCD symptoms and was not primarily designed to assess hoarding symptoms. It remains possible that some of the poor response seen in patients with hoarding symptoms, as opposed to other OCD patients, results from a relative lack of sensitivity of the Y-BOCS to changes in hoarding symptoms. Evidence in favor of this interpretation from the meta-analysis is that studies which used the Y-BOCS either as the sole criterion for measurement of response or to measure the change in symptoms reported a worse response in OCD patients with hoarding symptoms compared with OCD patients without hoarding symptoms. Evidence against this interpretation from the meta-analysis was that (1) this analysis of reported effects of hoarding treatment outcome differences stratified by response criteria did not even reach trend levels of significance and (2) even meta-analysis of studies that used response criteria other than the Y-BOCS (for example, the DY-BOCS or CGI) demonstrated poor response of OCD patients with hoarding symptoms compared with OCD patients without hoarding symptoms. Because of these issues in previous studies, it remains critical that further treatment research examines the efficacy of traditional pharmacological interventions for OCD in Hoarding Disorder using appropriate and validated measures for the condition. 50 The findings of our meta-analysis have important treatment and research implications for individuals with hoarding symptoms. Treatment research in hoarding should focus on whether existing treatments for OCD are effective in hoarding disorder at all. 51, 52 The reduced response of OCD patients with hoarding symptoms to traditional OCD treatments suggests only that these treatments are less effective in this population, not necessarily that they are not effective at all. Selective serotonin reuptake inhibitors, the first-line pharmacological treatment for OCD, are still recommended as first-line pharmacotherapy in patients with hoarding even though they have never been studied in a randomized, placebo-controlled trial in patients with hoarding disorder. 52 For treatments such as cognitive-behavioral therapy, research should focus on how they can be modified to improve outcomes. 19, 53 Most of the trials in this meta-analysis included cognitive behavioral therapy interventions that were designed for OCD patients rather than for hoarding disorders. Although initial studies of cognitive behavioral therapy interventions specifically designed for individuals with hoarding disorders are promising, additional research is needed to confirm and refine these targeted interventions. 18, 19 It is also unclear how much of the differences in rates of treatment-response between OCD patients with and without hoarding symptoms are due to a relative insensitivity in the Y-BOCS to changes in hoarding symptoms. Results from stratified subgroup analysis in this meta-analysis suggest that issues with rating scales do not explain much of the poor treatment response observed in OCD patients with hoarding symptoms. For assessing symptom improvement in hoarding subjects, the use of rating scales specific to hoarding symptoms will likely be more sensitive in detecting these changes. 50, 54, 55 Our meta-analysis suggests that OCD patients with hoarding symptoms have a poorer response to evidence-based, traditional OCD treatments. DSM-5 has now formalized the distinction between hoarding and OCD that has emerged in the clinical, neuroimaging and genetic research. Hopefully, the new recognition of hoarding disorder will lead to improved treatment of individuals who suffer from this condition.
